Key facts about GLP-1-related gastroparesis: How it happens: GLP-1 drugs slow gastric emptying as part of their mechanism, but this effect becomes excessive in some people Whos at risk: Those with pre-existing digestive disorders, prior gastric surgery, long-standing diabetes, or elderly patients face higher risk Timeline: Symptoms can appear at any point during treatment, especially during dose increases Reversibility: Most cases improve after dose reduction or medication discontinuation, with recovery taking days to several months Management options: Dietary changes (smaller, low-fat meals), slower dose escalation, supportive medications, or temporary drug cessation Seek immediate medical attention for severe vomiting, dehydration signs, intense abdominal pain, or blood in vomit or stool
Neuropathy: L-Carnitine supplementation may improve nerve function and reduce pain in people with diabetic neuropathy, a type of nerve damage that can occur in people with diabetes
Local regeneration of cortisol by 11beta-HSD1 contributes to insulin resistance of the granulosa cells in PCOS
Diabetes 38 , 364371 (2014)